Deborah Dowell
YOU?
Author Swipe
View article: Why have overdose deaths decreased? Widespread fentanyl saturation and decreased drug use among key drivers
Why have overdose deaths decreased? Widespread fentanyl saturation and decreased drug use among key drivers Open
While overdose deaths remain high in the United States (U.S.), national data show a 25.0% decline in overdose deaths from the year ending in March 2025 compared to the previous year. Reductions since 2015 in the population exposed to overd…
View article: Prescription Opioid Use Disorder Among Adults Reporting Prescription Opioid Use With or Without Misuse in the United States
Prescription Opioid Use Disorder Among Adults Reporting Prescription Opioid Use With or Without Misuse in the United States Open
Conclusions: Moderate-to-severe POUD is more frequent among adults who report misusing prescription opioids. However, 62% of adults with POUD do not report prescription opioid misuse, suggesting that adults who are treated with prescriptio…
View article: Reported Xylazine Use Among Adults Aged ≥18 Years Evaluated for Substance Use Treatment — United States, July 2022–September 2023
Reported Xylazine Use Among Adults Aged ≥18 Years Evaluated for Substance Use Treatment — United States, July 2022–September 2023 Open
Xylazine has been increasingly detected in illegally manufactured fentanyl (IMF) products and overdose deaths in the United States; most xylazine-involved overdose deaths involve IMF. A convenience sample of U.S. adults aged ≥18 years was …
View article: Treatment for Opioid Use Disorder: Population Estimates — United States, 2022
Treatment for Opioid Use Disorder: Population Estimates — United States, 2022 Open
In 2022, 81,806 opioid-involved overdose deaths were reported in the United States, more than in any previous year. Medications for opioid use disorder (OUD), particularly buprenorphine and methadone, substantially reduce overdose-related …
View article: SARS-CoV-2 Reduction in Shared Indoor Air—Reply
SARS-CoV-2 Reduction in Shared Indoor Air—Reply Open
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Sum…
View article: CDC Clinical Practice Guideline for Prescribing Opioids for Pain<b>—</b>United States, 2022
CDC Clinical Practice Guideline for Prescribing Opioids for Pain<b>—</b>United States, 2022 Open
This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016 (M…
View article: Reducing SARS-CoV-2 in Shared Indoor Air
Reducing SARS-CoV-2 in Shared Indoor Air Open
Reducing SARS-CoV-2 in Shared Indoor Air SARS-CoV-2 replicates in the respiratory tract and spreads through exhalation of infectious respiratory particles.The chances of transmission increase the longer an uninfected person stays in an enc…
View article: Real-Time CDC Consultation during the COVID-19 Pandemic—United States, March–July, 2020
Real-Time CDC Consultation during the COVID-19 Pandemic—United States, March–July, 2020 Open
Context: In response to the COVID-19 pandemic, the Centers for Disease Prevention and Control (CDC) clinicians provided real-time telephone consultation to healthcare providers, public health practitioners, and health department personnel.…
View article: Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017
Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017 Open
Indication-specific opioid prescribing rates were not always aligned with existing guidelines. Potential inconsistencies between prescribing practice and clinical recommendations, such as for acute and chronic back pain, highlight opportun…
View article: Bridging the Gap Among Clinical Practice Guidelines for Pain Management in Cancer and Sickle Cell Disease
Bridging the Gap Among Clinical Practice Guidelines for Pain Management in Cancer and Sickle Cell Disease Open
Opioids are a critical component of pain relief strategies for the management of patients with cancer and sickle cell disease. The escalation of opioid addiction and overdose in the United States has led to increased scrutiny of opioid pre…
View article: Patient-Centered Reduction or Discontinuation of Long-term Opioid Analgesics
Patient-Centered Reduction or Discontinuation of Long-term Opioid Analgesics Open
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JA…
View article: No Shortcuts to Safer Opioid Prescribing
No Shortcuts to Safer Opioid Prescribing Open
No Shortcuts to Safer Opioid Prescribing The CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain has largely been embraced by the medical and health policy communities. Unfortunately, some policies and practices purportedly deriv…
View article: US Emergency Department Visits for Acute Harms From Prescription Opioid Use, 2016–2017
US Emergency Department Visits for Acute Harms From Prescription Opioid Use, 2016–2017 Open
Objectives. To estimate the number of US emergency department visits for prescription opioid harms by patient characteristics, intent, clinical manifestations, and active ingredient. Methods. We used data from medical record–based surveill…
View article: County-Level Opioid Prescribing in the United States, 2015 and 2017
County-Level Opioid Prescribing in the United States, 2015 and 2017 Open
Assessment of Racial/Ethnic and Income Disparities in the Prescription of Controlled Medications in California
View article: Data Errors in the Text and Tables
Data Errors in the Text and Tables Open
In Reply Mr Rudman and colleagues question whether mandatory review of PDMP data reduces opioid overdose death rates.They observe that the 4 states with mandated PDMP policies examined in one study 1 each experienced increases in heroin-re…
View article: Underlying Factors in Drug Overdose Deaths
Underlying Factors in Drug Overdose Deaths Open
In this Viewpoint, authors from the US CDC's National Center for Injury Prevention and Control discuss infrastructure investments, legal changes, and clinical and public health strategies for reducing overdose deaths among opioid users.
View article: Contribution of Opioid-Involved Poisoning to the Change in Life Expectancy in the United States, 2000-2015
Contribution of Opioid-Involved Poisoning to the Change in Life Expectancy in the United States, 2000-2015 Open
This study uses US National Vital Statistics mortality data to assess change in US life expectancy from 2000 to 2015 attributable to opioid-involved poisonings.
View article: Changing the Conversation About Opioid Tapering
Changing the Conversation About Opioid Tapering Open
Editorials1 August 2017Changing the Conversation About Opioid TaperingDeborah Dowell, MD, MPH and Tamara M. Haegerich, PhDDeborah Dowell, MD, MPHFrom Centers for Disease Control and Prevention, Atlanta, Georgia. and Tamara M. Haegerich, Ph…
View article: Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015
Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015 Open
Despite reductions in opioid prescribing in some parts of the country, the amount of opioids prescribed remains high relative to 1999 levels and varies substantially at the county-level. Given associations between opioid prescribing, opioi…
View article: Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates
Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates Open
To address the opioid overdose epidemic in the United States, states have implemented policies to reduce inappropriate opioid prescribing. These policies could affect the coincident heroin overdose epidemic by either driving the substituti…
View article: Expanded Explanation of the Sample Size Calculation
Expanded Explanation of the Sample Size Calculation Open
Michael C. Reade, DPhil, FCICM; Glenn M. Eastwood, RN, PhD; Rinaldo Bellomo, MD, FCICM; Michael Bailey, PhD; Andrew Bersten, MD, FCICM; Benjamin Cheung, MBBS, FCICM; Andrew Davies, MBBS, FCICM; Anthony Delaney, PhD, FCICM; Angaj Ghosh, MBB…
View article: Public Health Detailing—A Successful Strategy to Promote Judicious Opioid Analgesic Prescribing
Public Health Detailing—A Successful Strategy to Promote Judicious Opioid Analgesic Prescribing Open
Objectives. To evaluate knowledge and prescribing changes following a 2-month public health detailing campaign (one-to-one educational visits) about judicious opioid analgesic prescribing conducted among health care providers in Staten Isl…
View article: Using the CDC Guideline and Tools for Opioid Prescribing in Patients with Chronic Pain.
Using the CDC Guideline and Tools for Opioid Prescribing in Patients with Chronic Pain. Open
The new CDC guideline is intended to help clinicians decide whether and how to prescribe opioids for chronic pain; offer safer, more effective care for patients with chronic pain; improve clinician-patient communication; and prevent opioid…